2 Growth Stocks to Buy in the Tariff-Fueled Market Correction [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
Unless a company's investment thesis has changed because of recent developments, market downturns aren't a good enough reason for most investors to sell. For those who can afford it without blowing their budget, it's actually a great idea to pick up shares of top companies on the dip during a correction. With that in mind, here are two excellent growth-oriented companies to buy in the ongoing market meltdown: tech giant Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and medical device maker DexCom (NASDAQ: DXCM) President Donald Trump's tariffs threaten to send the economy into a recession. If that happens, Alphabet, Google's parent company, could suffer. Alphabet makes the bulk of its revenue from advertising. During challenging
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. ShareholdersGlobeNewswire
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at Mizuho to a "strong-buy" rating.MarketBeat
- The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM [CNET News]CNET News
- FDA Approves New DexCom Diabetes Device [Yahoo! Finance]Yahoo! Finance
- Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/13/25 - Miss
DXCM
Sec Filings
- 3/31/25 - Form 3
- 3/27/25 - Form ARS
- 3/27/25 - Form DEFA14A
- DXCM's page on the SEC website